Jointown Pharmaceutical Group Co., Ltd

Shanghai Stock Exchange:600998.SS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

🛍 E-commerce

Location

China

Market Cap

USD 3.54 B

Share Price

USD 0.70

Avg Daily Volume

28,814,660

Change (1 day)

-0.00%

Change (1 year)

1.00%

Change (YTD)

0.15%

Jointown Pharmaceutical Group Co., Ltd Operating Income Margin for the year ending December 31, 2024: 2.39%

Jointown Pharmaceutical Group Co., Ltd Operating Income Margin is 2.39% for the year ending December 31, 2024, a 18.93% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Jointown Pharmaceutical Group Co., Ltd Operating Income Margin for the year ending December 31, 2023 was 2.01%, a -35.14% change year over year.
Jointown Pharmaceutical Group Co., Ltd Operating Income Margin for the year ending December 31, 2022 was 3.10%, a 5.77% change year over year.
Jointown Pharmaceutical Group Co., Ltd Operating Income Margin for the year ending December 31, 2021 was 2.93%, a -25.24% change year over year.
Jointown Pharmaceutical Group Co., Ltd Operating Income Margin for the year ending December 31, 2020 was 3.93%, a 7.74% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Operating Income Margin	Gross Profit Margin	EBIT Margin	EBITDA Margin

Shanghai Stock Exchange: 600998.SS

Jointown Pharmaceutical Group Co., Ltd

CEO	Mr. Yihua Gong
IPO Date	Nov. 2, 2010
Location	China
Headquarters	No. 8, Longyang Avenue
Employees	30,169
Sector	🏥 Health Care
Industries Pharmaceuticals 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 🛍 E-commerce

Description

Jointown Pharmaceutical Group Co., Ltd provides marketing, distribution, and logistics services for digital pharmaceutical businesses. It wholesales Chinese herbal medicines, Chinese patent medicines, chemical medicinal materials, chemical medicine preparations, antibiotic preparations, biochemical drugs, biological products, chemical raw materials, and medical toxic drugs. The company was founded in 1999 and is based in Wuhan, China.